Trump Administration Ends $258 Million HIV Vaccine Program
Tap title to read story
0:00 / 0:32
The Trump administration abruptly ended a $258 million HIV vaccine research program at Duke University and Scripps Research Institute. The program, involving numerous collaborators, had broad applications beyond HIV, including COVID-19 treatments and other therapies. NIH leadership cited a review as the reason for termination, delivering the news Friday to program leaders. This decision halts significant progress in HIV vaccine development.
More context
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
